Covaxin 50 pc effective against symptomatic COVID: Lancet study

Nov 24, 2021

New Delhi [India], November 24 : Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to...

Walking more can improve people's health, longevity: Study

Mar 13, 2022

Amherst [US], March 13 : Researchers have found that taking more steps a day helps lower the risk of premature death. The study was...

Lancet study stating that protection offered by Covishield declines after 3 months is misquoted, say experts

Dec 23, 2021

New Delhi [India], December 23 : The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines...

Authors retract Lancet study on HCQ drug over unavailability of full data set

Jun 05, 2020

Washington D.C. [USA], June 5 : Three authors involved in a Lancet article that drew scrutiny over the trial of the antimalarial drug-- hydroxychloroquine--...

Half of Covid survivors show one symptom even after 2 years: Lancet Journal

May 12, 2022

New Delhi [India], May 12 : Two years after getting infected with COVID-19, health outcomes of people who have suffered hospitalisation, reported at least...

Oxford's coronavirus vaccine 'safe, immunogenic': Study

Jul 20, 2020

London [UK], July 20 : A vaccine candidate developed at the University of Oxford has shown encouraging results in early human testing and appears...